Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

World’s most expensive drug approved to treat hemophilia at $3.5 million a dose

U.S. regulators approved CSL Behring’s hemophilia B gene therapy, a one-off infusion that frees patients from regular treatments but costs $3.5 million a dose, making it the most expensive medicine in the world.

Tribune News Service

California’s COVID-19 ‘misinformation’ law chills constitutionally protected speech

California is threatening to punish doctors whose advice deviates from the “scientific consensus.”

Chicago Sun-Times

Opioid maker Endo to be monitored by Obama's former drug czar for $25K a month

Under pressure from people impacted by the nation's ongoing opioid crisis, a New York judge has confirmed Gil Kerlikowske, a former national drug czar in the Obama administration, as an outside monitor over Endo International's opioid business. The Chester County drug firm is reorganizing in bankruptcy court.

The Philadelphia Inquirer

From analysis to the latest developments in health,
read the most diverse news in one place.

'Women experiencing menopause have had to suffer in silence - it's time for change'

Eva Simpson on the news we should all welcome with cheers not sneers - the NHS issuing new guidelines for protecting and helping staff who are going through the menopause

Daily Mirror

Elon Musk's Twitter Blue fiasco: Governments need to better regulate how companies use trademarks

Until recently, Twitter’s blue checkmark logo was (for better or worse) a trusted mark of authenticity. But under the façade of democratizing the platform, Elon Musk allowed the blue checkmark to be purchased by anyone — with unsurprisingly chaotic results.

The Conversation

3 Stocks to Buy This Month if You Haven’t Already

Although the stock market has seen a decline in inflation for October, it is far from the Fed’s target, and rate hikes might continue. However, the anticipation of a strong stock market rebound in 2023 is rising. So, we think it could be wise to load up on fundamentally sound…

StockNews.com

Vapes, e-cigarettes linked to higher risk of tooth decay and cavities, study finds

Each fruity plume of vapour from an e-cigarette may have not-so-sweet repercussions for your pearly whites, according to a study into tooth decay risk.

ABC News

Read news from The Economist, FT, and more,
with one subscription

Women associated with CervicalCheck group refused treatment by clinicians as one claims she was 'treated like a leper'

One woman described being 'treated like a leper' after she was questioned by a clinician about any association with the 221+ group

Irish Mirror

Measles now an imminent global threat due to pandemic, say WHO and CDC

There is now an imminent threat of measles spreading in various regions globally, as COVID-19 led to a steady decline in vaccination coverage and weakened surveillance of the disease, the World Health Organization (WHO) and the U.S. public health agency said on Wednesday.

Reuters

WHO, CDC: A record 40 million kids miss measles vaccine dose

The World Health Organization and the U.S. Centers for Disease Control and Prevention say measles immunization has dropped significantly since the coronavirus pandemic began, resulting in a record high of nearly 40 million children missing a vaccine dose last year

The Independent UK

Revealed: Tory peer Michelle Mone secretly received £29m from ‘VIP lane’ PPE firm

Documents suggest husband passed on money from PPE Medpro, which secured £200m contracts after Mone lobbied ministers

The Guardian - UK

What are the key moments from the South African President’s visit to the UK?

Here are some of the key moments from the last two days, as the South African President’s visit to the UK continues.

Evening Standard

Is This Biotech Stock a Buy for Under $3?

Biotech company Bionano Genomics (BNGO) has beaten analysts’ top-line estimate in the third quarter. However, its cash and cash equivalents balance has declined year-over-year. Therefore, is it a buy now under $3? Read on to find out….

StockNews.com

California’s ‘tripledemic’ of viruses is on the rise. Here’s how to care for a sick loved one

Trying to avert a heavy surge in respiratory illnesses, California’s leading public health officials once again stressed on Tuesday that state residents should do all they can to prevent the spread of COVID-19, the flu and respiratory syncytial virus, or RSV, as they gather for the holidays.

Tribune News Service

Get all your
news in one place.

100’s of premium titles.
One news app.

Belfast Live

Scale of drugs problem contributes to existence of paramilitary groups, MPs told

"The harms of paramilitarism are much broader and will need a tailored and very different process."

The Guardian - US

Gene therapy at $3.5m a dose approved for US adults with hemophilia B

Hemgenix frees patients from repeated treatments but initial cost makes it most expensive medicine in the world

Reuters

China's Zhengzhou, Shenyang to tighten COVID rules

Eight districts in the central Chinese city of Zhengzhou will conduct mass COVID-19 testing for five consecutive days from Nov. 25, state television CCTV reported on Wednesday.

Tribune News Service

As STDs proliferate, companies rush to market at-home test kits. But are they reliable?

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

1 Stock to Buy Now That Could Make You Rich in 2023

Biopharmaceutical major Bristol-Myers Squibb Company (BMY) beat the consensus earnings and revenue estimates in the third quarter. Given its strong product pipeline, strategic acquisitions, discounted valuation, high profitability, strong financials, and attractive dividends, investors could buy the stock now. Read more….

Reuters

Britain and South Africa agree health partnership on second day of state visit

Britain and South Africa on Wednesday announced a new health and science partnership to mark the second day of President Cyril Ramaphosa's state visit to London, the first such official guest hosted by Britain's King Charles.

The Independent UK

UK and South Africa to strengthen health and climate partnership

The two nations signed an agreement during South African President Cyril Ramaphosa’s state visit to the UK.

The Japan News/Yomiuri

COVID pill approval ups pandemic arsenal

The health ministry has granted emergency approval for a COVID-19 pill developed by Shionogi Co., opening the door for Japan's first domestically produced oral medicine for the virus to become available as soon as early December.

The Times of India

Odisha launches Amlan to reduce anaemia

BHUBANESWAR: The Odisha government on Wednesday launched Anaemia Mukta Lakhya Abhiyan (Amlan), a multi-departmental campaign to reduce anaemia or haemoglobin deficiency in the state.

Axios

The growing menopause-at-work market

Little discussed and poorly understood, menopause — and the market for helping treat its accompanying symptoms — is gaining more attention when it comes to employer benefits.

The Independent UK

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

1 … 94 95 96 97

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.